Keisuke Oboki

Years Active: 2017-2020
Publications (10 Years): 4

Tokyo Metropolitan Institute of Medical Science

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tokyo Metropolitan Institute of Medical Science

Japan

Associate Director

Publications

Daichi Sadato, Mina Ogawa, Chizuko Hirama, Tsunekazu Hishima, Shin-Ichiro Horiguchi, Yuka Harada, Tatsu Shimoyama, Masanari Itokawa, Kazuteru Ohashi, Keisuke Oboki
Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort. FEBS open bio 10 (3) (2020)
Yuho Najima, Daichi Sadato, Yuka Harada, Keisuke Oboki, Chizuko Hirama, Takashi Toya, Noriko Doki, Kyoko Haraguchi, Kota Yoshifuji, Megumi Akiyama, Kyoko Inamoto, Aiko Igarashi, Takeshi Kobayashi, Kazuhiko Kakihana, Yoshiki Okuyama, Hisashi Sakamaki, Hironori Harada, Kazuteru Ohashi
Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT. Bone marrow transplantation 56 (2) (2020)
Daichi Sadato, Tomio Ono, Saki Gotoh-Saito, Naoki Kajiwara, Namiko Nomura, Masako Ukaji, Liying Yang, Kenji Sakimura, Youichi Tajima, Keisuke Oboki, Futoshi Shibasaki
Eukaryotic translation initiation factor 3 (eIF3) subunit e is essential for embryonic development and cell proliferation. FEBS open bio 8 (8) (2018)
Fumiko Endo, Tsutomu Tabata, Daichi Sadato, Machiko Kawamura, Noriyuki Ando, Keisuke Oboki, Masako Ukaji, Kaoru Kobayashi, Yukuharu Kobayashi, Tomoaki Ikeda, Futoshi Shibasaki
Development of a simple and quick immunochromatography method for detection of anti-HPV-16/-18 antibodies. PloS one 12 (2) (2017)

Keisuke Oboki.css-eqlu8i{font-size:small;padding-left:4px;}